PHI with Symmetrical gangrene
How does this condition affect your private health insurance?
Symmetric gangrene, or purpura fulminans, is a rare, life-threatening condition characterized by acute onset of rapidly progressive skin hemorrhage and necrosis, often affecting distal extremities symmetrically. It arises from an underlying severe illness, most commonly bacterial sepsis, especially meningococcal, but also other infections, autoimmune conditions, or malignancy. Pathophysiology involves microvascular thrombosis due to severe disseminated intravascular coagulation (DIC) and protein C deficiency. This leads to ischemic tissue damage, particularly in acral areas, progressing to dry or wet gangrene. Early recognition and aggressive treatment of the underlying cause, along with supportive care, are crucial.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Days to weeks for acute destructive phase
Duration of Illness (Lifetime)
Acute, life-threatening event; long-term consequences are permanent
Cost of Treatment (Initial)
Extremely high, often exceeding hundreds of thousands of dollars
Cost of Treatment (Lifetime)
Extremely high, including long-term rehabilitation and prosthetics if amputations occur
Mortality Rate
High (20-60%), varying significantly with underlying cause and severity
Risk of Secondary Damages
Very high (e.g., limb amputations, extensive scarring, organ damage, psychological impact)
Probability of Full Recovery
Low, as permanent tissue loss (e.g., amputations) is common
Underlying Disease Risk
Nearly 100%, as it is a severe complication of underlying conditions like sepsis, autoimmune diseases, or malignancy